Recital 4, Regulation (EU) 2026/2042

In forcesince 11 Sep 2026

In its opinion, the Agency concludes that the proposed differences between the biocidal product ‘OXTERIL® 350 VHP’ and the related reference biocidal product family ‘Evonik’s Hydrogen Peroxide Product Family’ are limited to information which can be the subject of an administrative change in accordance with Commission Implementing Regulation (EU) No 354/2013 [Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj).], and that based on the assessment of the related reference biocidal product family ‘Evonik’s Hydrogen Peroxide Product Family’ and subject to compliance with the draft SPC, the biocidal product ‘OXTERIL® 350 VHP’ meets the conditions laid down in Article 19(1) of Regulation (EU) No 528/2012.